{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T19:17:07Z","timestamp":1771269427042,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KX2021"],"award-info":[{"award-number":["01KX2021"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jcv.2022.105119","type":"journal-article","created":{"date-parts":[[2022,2,19]],"date-time":"2022-02-19T18:21:43Z","timestamp":1645294903000},"page":"105119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Determining the reliability of rapid SARS-CoV-2 antigen detection in fully vaccinated individuals"],"prefix":"10.1016","volume":"148","author":[{"given":"Nareshkumar","family":"Poopalasingam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Korenkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artem","family":"Ashurov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janina","family":"Strobel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Fish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Hellmich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henning","family":"Gruell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Heger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2022.105119_bib0001","first-page":"eabi9069","article-title":"Impact of community masking on COVID-19: a cluster-randomized trial in Bangladesh","author":"Abaluck","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jcv.2022.105119_bib0002","unstructured":"NHS. How to avoid catching and spreading coronavirus (COVID-19). https:\/\/www.nhs.uk\/conditions\/coronavirus-covid-19\/how-to-avoid-catching-and-spreading-coronavirus-covid-19\/. Accessed 14.12.2021."},{"key":"10.1016\/j.jcv.2022.105119_bib0003","unstructured":"CDC. Contact tracing for COVID-19. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/php\/contact-tracing\/contact-tracing-plan\/contact-tracing.html. Accessed 14.12.2021."},{"key":"10.1016\/j.jcv.2022.105119_bib0004","unstructured":"CDC. COVID-19 vaccine booster shots. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/booster-shot.html. Accessed 14.12.2021."},{"key":"10.1016\/j.jcv.2022.105119_bib0005","unstructured":"CDC. Interim guidance for antigen testing for SARS-CoV-2. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/lab\/resources\/antigen-tests-guidelines.html. Accessed 14.12.2021."},{"key":"10.1016\/j.jcv.2022.105119_bib0006","unstructured":"WHO. Antigen-detection in the diagnosis of SARS-CoV-2 infection. 2021. https:\/\/www.who.int\/publications\/i\/item\/antigen-detection-in-the-diagnosis-of-sars-cov-2infection-using-rapid-immunoassays. Accessed 14.12.2021."},{"key":"10.1016\/j.jcv.2022.105119_bib0007","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd5393","article-title":"Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening","volume":"7","author":"Larremore","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jcv.2022.105119_bib0008","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1126\/science.abf9648","article-title":"The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia","volume":"372","author":"Pavelka","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jcv.2022.105119_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10020328","article-title":"The comparative clinical performance of four SARS-CoV-2 rapid antigen tests and their correlation to infectivity In Vitro","volume":"10","author":"Kohmer","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jcv.2022.105119_bib0010","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00896-21","article-title":"Evaluation of a rapid antigen test to detect SARS-CoV-2 infection and identify potentially infectious individuals","volume":"59","author":"Korenkov","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2022.105119_bib0011","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1093\/cid\/ciaa1890","article-title":"Field performance and public health response using the BinaxNOWTM rapid severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen detection assay during community-based testing","volume":"73","author":"Pilarowski","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2022.105119_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9010058","article-title":"Performance of a Point-of-Care test for the rapid detection of SARS-CoV-2 antigen","volume":"9","author":"Stromer","year":"2020","journal-title":"Microorganisms."},{"key":"10.1016\/j.jcv.2022.105119_bib0013","unstructured":"U.S. Food & Drug Administration. FDA Takes key action in fight against COVID-19 by issuing emergency use authorization for first COVID-19 vaccine. 2020. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19. Accessed 14.12.2021."},{"key":"10.1016\/j.jcv.2022.105119_bib0014","unstructured":"U.S. Food & Drug Administration. FDA takes additional action in fight against COVID-19 by issuing emergency use authorization for second COVID-19 vaccine. 2020. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-takes-additional-action-fight-against-covid-19-issuing-emergency-use-authorization-second-covid. Accessed 14.12.2021."},{"key":"10.1016\/j.jcv.2022.105119_bib0015","unstructured":"European Medicines Agency. Vaxzevria (previously COVID-19 Vaccine AstraZeneca). 2021. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/vaxzevria-previously-covid-19-vaccine-astrazeneca. Accessed 14.12.2021."},{"key":"10.1016\/j.jcv.2022.105119_bib0016","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1056\/NEJMoa2113017","article-title":"Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase","volume":"385","author":"El Sahly","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2022.105119_bib0017","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2022.105119_bib0018","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2022.105119_bib0019","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1056\/NEJMoa2114583","article-title":"Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months","volume":"385","author":"Levin","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2022.105119_bib0020","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1038\/s41467-021-26672-3","article-title":"Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine","volume":"12","author":"Mizrahi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jcv.2022.105119_bib0021","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(21)01642-1","article-title":"Spike-antibody waning after second dose of BNT162b2 or ChAdOx1","volume":"398","author":"Shrotri","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2022.105119_bib0022","unstructured":"CDC. Rates of COVID-19 cases and deaths by vaccination status. https:\/\/covid.cdc.gov\/covid-data-tracker\/#rates-by-vaccine-status. Accessed 14.12.2021."},{"key":"10.1016\/j.jcv.2022.105119_bib0023","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2021.26.37.2100824","article-title":"Characterisation of vaccine breakthrough infections of SARS-CoV-2 Delta and Alpha variants and within-host viral load dynamics in the community, France, June to July 2021","volume":"26","author":"Blanquart","year":"2021","journal-title":"Euro Surveill."},{"key":"10.1016\/j.jcv.2022.105119_bib0024","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1056\/NEJMoa2105000","article-title":"Vaccine breakthrough infections with SARS-CoV-2 variants","volume":"384","author":"Hacisuleyman","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2022.105119_bib0025","unstructured":"Kissler SM, Fauver JR, Mack C, Tai CG, Breban MI, Watkins AE, et\u00a0al. Viral dynamics of SARS-CoV-2 variants in vaccinated and unvaccinated persons. N. Engl. J. Med.."},{"key":"10.1016\/j.jcv.2022.105119_bib0026","doi-asserted-by":"crossref","unstructured":"Levine-Tiefenbrun M, Yelin I, Alapi H, Katz R, Herzel E, Kuint J, et\u00a0al. Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2. Nat. Med.. 2021.","DOI":"10.1101\/2021.08.29.21262798"},{"key":"10.1016\/j.jcv.2022.105119_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2021.105018","article-title":"Safe and effective pool testing for SARS-CoV-2 detection","volume":"145","author":"Wunsch","year":"2021","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2022.105119_bib0028","unstructured":"Our World in Data. Coronavirus (COVID-19) Vaccinations. 2022. https:\/\/ourworldindata.org\/covid-vaccinations. Accessed 14.02.2022."},{"key":"10.1016\/j.jcv.2022.105119_bib0029","unstructured":"The New York Times. Tracking coronavirus vaccinations around the world. 2022. https:\/\/www.nytimes.com\/interactive\/2021\/world\/covid-vaccinations-tracker.html. Accessed 14.02.2022."},{"key":"10.1016\/j.jcv.2022.105119_bib0030","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.15585\/mmwr.mm7031e2","article-title":"Outbreak of SARS-CoV-2 infections, including COVID-19 vaccine breakthrough infections, associated with large public gatherings - Barnstable county, Massachusetts, July 2021","volume":"70","author":"Brown","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.jcv.2022.105119_bib0031","doi-asserted-by":"crossref","unstructured":"Chia PY, Xiang Ong SW, Chiew CJ, Ang LW, Chavatte JM, Mak TM, et\u00a0al. Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study. Clin. Microbiol. Infect.. 2021.","DOI":"10.1101\/2021.07.28.21261295"},{"key":"10.1016\/j.jcv.2022.105119_bib0032","doi-asserted-by":"crossref","unstructured":"Singanayagam A, Hakki S, Dunning J, Madon KJ, Crone MA, Koycheva A, et\u00a0al. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. Lancet Infect. Dis.. 2021.","DOI":"10.1016\/S1473-3099(21)00648-4"},{"key":"10.1016\/j.jcv.2022.105119_bib0035","article-title":"Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021","volume":"26","author":"de Gier","year":"2021","journal-title":"Euro Surveill."},{"key":"10.1016\/j.jcv.2022.105119_bib0036","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMc2106757","article-title":"Effect of vaccination on transmission of SARS-CoV-2","volume":"385","author":"Shah","year":"2021","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653222000555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653222000555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:15:48Z","timestamp":1761362148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653222000555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":34,"alternative-id":["S1386653222000555"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2022.105119","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determining the reliability of rapid SARS-CoV-2 antigen detection in fully vaccinated individuals","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2022.105119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105119"}}